Literature DB >> 10842513

Developments in the production and application of rabies vaccine for human use in China.

F T Lin1, N Lina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10842513     DOI： 10.1177/004947550003000108

Source DB:  PubMed          Journal:  Trop Doct        ISSN： 0049-4755            Impact factor:   0.731


× No keyword cloud information.
  2 in total

1.  Persistence of rabies antibody 5 years after postexposure prophylaxis with vero cell antirabies vaccine and antibody response to a single booster dose.

Authors:  Xiaowei Zhang; Zhenggang Zhu; Chuanlin Wang
Journal:  Clin Vaccine Immunol       Date:  2011-07-13

2.  Promising rabies vaccine for postexposure prophylaxis in developing countries, a purified vero cell vaccine produced in china.

Authors:  Chuanlin Wang; Xiaowei Zhang; Qingkun Song; Kun Tang
Journal:  Clin Vaccine Immunol       Date:  2010-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.